• linkedin
  • Increase Font
  • Sharebar

    9 Newly Approved Novel Drugs

    It's been a busy year for the FDA.

     

    Xermelo packaging

    5. Xermelo (telotristat ethyl), Lexicon Pharmaceuticals, Inc.

    Indications: A tryptophan hydroxylase inhibitor indicated for carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults whose diarrhea is adquately controlled by SSA therapy.

    Dosage: 250 mg tid with food.

    Contraindications: None

    Read the FDA statement here

    Read the full prescribing information here

    Previous ButtonNext Button

     

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available